Hepatology International

, Volume 4, Issue 3, pp 601–607 | Cite as

Hepatitis B virus genotyping by enzyme-linked immunosorbent assay in Taiwan

  • Shu-Fen Liu
  • Meng-Hsuan Hsieh
  • Nai-Jen Hou
  • Ming-Yen Hsieh
  • Jee-Fu Huang
  • Chia-Yen Dai
  • Ming-Lung Yu
  • Wan-Long Chuang
Original Article



Restriction fragment length polymorphism (RFLP) and enzyme-linked immunosorbent assay (ELISA) with monoclonal antibodies (mAbs) were used in this study to detect genotypes of HBV, and the efficiency and precision of ELISA using the mAbs for HBV genotype detection were also estimated.


The ELISA with mAbs method was used for the detection of HBV genotype in a Taiwanese population. The HBV genotypes of 100 chronic hepatitis B patients were determined by ELISA and were then compared with those obtained using RFLP.


Genotype B was found to be the most prevalent in this study (63% by RFLP; 62% by ELISA) followed by genotype C (31% by RFLP; 35% by ELISA). There was no significant difference between the results obtained by RFLP and ELISA (P = 0.75). The ELISA overall genotypeable rate, the correct genotyping rate from genotypeable specimens, and the concordance of the HBV genotyping assay was 96.00, 94.79, and 91.00%; for the ELISA HBV genotyping assay for genotype B specimens was 96.77, 100.00, and 96.77%; and for genotype C specimens was 97.14, 91.18, and 88.57%, respectively. The mean HBV DNA level was higher in the specimens that could be genotyped by both RFLP and ELISA samples (6.24 ± 1.77 vs. 2.34 ± 0.90, log IU/ml), and a significant difference in terms of HBV DNA level of more than 2 × 103 IU/ml was identified between the genotyped RFLP samples (P < 0.001).


ELISA is a practical and a useful method for HBV genotyping in a clinical setting in Taiwan, in particular for patients with lower levels of HBV DNA.


Hepatitis B virus Genotype ELISA RFLP 



This study was supported by grants from the Taiwan Liver Research Foundation, Taiwan.

Conflict of interest



  1. 1.
    Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 2004;11:97–107CrossRefPubMedGoogle Scholar
  2. 2.
    Lok AS. Chronic hepatitis B. N Engl J Med 2002;346:1682–1683CrossRefPubMedGoogle Scholar
  3. 3.
    Szabo E, Paska C, Kaposi Novak P, Schaff Z, Kiss A. Similarities and differences in hepatitis B and C virus induced hepatocarcinogenesis. Pathol Oncol Res 2004;10:5–11CrossRefPubMedGoogle Scholar
  4. 4.
    Anthony PP. Hepatocellular carcinoma: an overview. Histopathology 2001;39:109–118CrossRefPubMedGoogle Scholar
  5. 5.
    Okuda K. Hepatocellular carcinoma. J Hepatol 2000;32:225–237CrossRefPubMedGoogle Scholar
  6. 6.
    Courouce-Pauty AM, Plancon A, Soulier JP. Distribution of HBsAg subtypes in the world. Vox Sang 1983;44:197–211CrossRefPubMedGoogle Scholar
  7. 7.
    Norder H, Courouce AM, Magnius LO. Complete genomes, phylogenetic relatedness, and structural proteins of six strains of the hepatitis B virus, four of which represent two new genotypes. Virology 1994;198:489–503CrossRefPubMedGoogle Scholar
  8. 8.
    Okamoto H, Imai M, Usuda S, Tanaka E, Tachibana K, Mishiro S, et al. Hemagglutination assay of polypeptide coded by the pre-S region of hepatitis B virus DNA with monoclonal antibody: correlation of pre-S polypeptide with the receptor for polymerized human serum albumin in serums containing hepatitis B antigens. J Immunol 1985;134:1212–1216PubMedGoogle Scholar
  9. 9.
    Okamoto H, Tsuda F, Sakugawa H, Sastrosoewignjo RI, Imai M, Miyakawa Y, et al. Typing hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes. J Gen Virol 1988;69(Pt 10):2575–2583CrossRefPubMedGoogle Scholar
  10. 10.
    FKaY Tanaka, Kramvis A, Simmonds P, Mizokami M. When Should “I” consider a new hepatitis B virus genotype? J Virol 2008;82:8241–8242CrossRefGoogle Scholar
  11. 11.
    Tatematsu K, Tanaka Y, Kurbanov F, Sugauchi F, Mano S, Maeshiro T, et al. A genetic variant of hepatitis B virus divergent from known human and ape genotypes isolated from a Japanese patient and provisionally assigned to new genotype J. J Virol 2009;83:10538–10547CrossRefPubMedGoogle Scholar
  12. 12.
    Arauz-Ruiz P, Norder H, Robertson BH, Magnius LO. Genotype H: a new Amerindian genotype of hepatitis B virus revealed in Central America. J Gen Virol 2002;83:2059–2073PubMedGoogle Scholar
  13. 13.
    Vieth S, Manegold C, Drosten C, Nippraschk T, Gunther S. Sequence and phylogenetic analysis of hepatitis B virus genotype G isolated in Germany. Virus Genes 2002;24:153–156CrossRefPubMedGoogle Scholar
  14. 14.
    Kao JH. Hepatitis B viral genotypes: clinical relevance and molecular characteristics. J Gastroenterol Hepatol 2002;17:643–650CrossRefPubMedGoogle Scholar
  15. 15.
    Kao JH, Wu NH, Chen PJ, Lai MY, Chen DS. Hepatitis B genotypes and the response to interferon therapy. J Hepatol 2000;33:998–1002CrossRefPubMedGoogle Scholar
  16. 16.
    Wai CT, Chu CJ, Hussain M, Lok AS. HBV genotype B is associated with better response to interferon therapy in HBeAg(+) chronic hepatitis than genotype C. Hepatology 2002;36:1425–1430PubMedGoogle Scholar
  17. 17.
    Erhardt A, Blondin D, Hauck K, Sagir A, Kohnle T, Heintges T, et al. Response to interferon alfa is hepatitis B virus genotype dependent: genotype A is more sensitive to interferon than genotype D. Gut 2005;54:1009–1013CrossRefPubMedGoogle Scholar
  18. 18.
    Kao JH, Liu CJ, Chen DS. Hepatitis B viral genotypes and lamivudine resistance. J Hepatol 2002;36:303–304CrossRefPubMedGoogle Scholar
  19. 19.
    Palumbo E. Hepatitis B genotypes and response to antiviral therapy: a review. Am J Ther 2007;14:306–309CrossRefPubMedGoogle Scholar
  20. 20.
    Kao JH, Chen PJ, Lai MY, Chen DS. Genotypes and clinical phenotypes of hepatitis B virus in patients with chronic hepatitis B virus infection. J Clin Microbiol 2002;40:1207–1209CrossRefPubMedGoogle Scholar
  21. 21.
    Lindh M, Andersson AS, Gusdal A. Genotypes, nt 1858 variants, and geographic origin of hepatitis B virus–large-scale analysis using a new genotyping method. J Infect Dis 1997;175:1285–1293CrossRefPubMedGoogle Scholar
  22. 22.
    Repp R, Rhiel S, Heermann KH, Schaefer S, Keller C, Ndumbe P, et al. Genotyping by multiplex polymerase chain reaction for detection of endemic hepatitis B virus transmission. J Clin Microbiol 1993;31:1095–1102PubMedGoogle Scholar
  23. 23.
    Mizokami M, Nakano T, Orito E, Tanaka Y, Sakugawa H, Mukaide M, et al. Hepatitis B virus genotype assignment using restriction fragment length polymorphism patterns. FEBS Lett 1999;450:66–71CrossRefPubMedGoogle Scholar
  24. 24.
    Usuda S, Okamoto H, Iwanari H, Baba K, Tsuda F, Miyakawa Y, et al. Serological detection of hepatitis B virus genotypes by ELISA with monoclonal antibodies to type-specific epitopes in the preS2-region product. J Virol Methods 1999;80:97–112CrossRefPubMedGoogle Scholar
  25. 25.
    Mizuochi T, Okada Y, Umemori K, Mizusawa S, Sato S, Yamaguchi K. Reactivity of genotypically distinct hepatitis B virus surface antigens in 10 commercial diagnostic kits available in Japan. Jpn J Infect Dis 2005;58:83–87PubMedGoogle Scholar
  26. 26.
    Yu ML, Wang LY, Chuang WL, Dai CY, Sung MH, Chen SC, et al. Serotyping and genotyping of hepatitis C virus in Taiwanese patients with type C chronic liver disease and uraemic patients on maintenance haemodialysis. J Gastroenterol Hepatol 2000;15:792–797CrossRefPubMedGoogle Scholar
  27. 27.
    Tanaka Y, Sugauchi F, Matsuuraa K, Naganuma H, Tatematsu K, Takagi K, et al. Evaluation of hepatitis B virus genotyping EIA kit. Rinsho Byori 2009;57:42–47PubMedGoogle Scholar
  28. 28.
    Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1977;74:5463–5467CrossRefPubMedGoogle Scholar
  29. 29.
    Tiollais P, Pourcel C, Dejean A. The hepatitis B virus. Nature 1985;317:489–495CrossRefPubMedGoogle Scholar
  30. 30.
    Mizokami M, Orito E, Ohba K, Ikeo K, Lau JY, Gojobori T. Constrained evolution with respect to gene overlap of hepatitis B virus. J Mol Evol 1997;44(Suppl 1):S83–S90CrossRefPubMedGoogle Scholar

Copyright information

© Asian Pacific Association for the Study of the Liver 2010

Authors and Affiliations

  • Shu-Fen Liu
    • 1
  • Meng-Hsuan Hsieh
    • 2
  • Nai-Jen Hou
    • 3
  • Ming-Yen Hsieh
    • 4
  • Jee-Fu Huang
    • 3
    • 4
  • Chia-Yen Dai
    • 1
    • 4
  • Ming-Lung Yu
    • 1
    • 4
  • Wan-Long Chuang
    • 1
    • 4
  1. 1.Hepatobiliary Division, Department of Internal MedicineKaohsiung Medical University HospitalKaohsiungTaiwan
  2. 2.Department of Occupational MedicineKaohsiung Municipal HsiaoKang HospitalKaohsiungTaiwan
  3. 3.Department of Internal MedicineKaohsiung Municipal HsiaoKang HospitalKaohsiungTaiwan
  4. 4.Faculty of Internal Medicine, College of MedicineKaohsiung Medical UniversityKaohsiungTaiwan

Personalised recommendations